1999PubMedRequires access

A Medicare prescription drug benefit.

Gluck Me

Open publisher page 19 citations

Abstract

Even though almost two-thirds of Medicare beneficiaries have some coverage for outpatient prescription drugs, pharmaceuticals are a major part of their out-of-pocket expenses and threaten the financial security of growing numbers of beneficiaries. Because pharmaceuticals are an integral part of modern health care, some have proposed adding a drug benefit to Medicare. Such proposals pose difficult questions of design, cost, and administration. A drug benefit could add between 7 and 13 percent per year to Medicare costs over the next decade. If such a benefit were added to Medicare, policymakers would have to decide who should bear these costs and whether subsidies should be provided to help lower income beneficiaries pay the portion of the costs borne by participants.

About this research paper

What this paper is about

Even though almost two-thirds of Medicare beneficiaries have some coverage for outpatient prescription drugs, pharmaceuticals are a major part of their out-of-pocket expenses and threaten the financial security of growing numbers of beneficiaries. Because pharmaceuticals are an integral part of modern health care, some have proposed adding a drug benefit to Medicare. Such proposals pose difficult questions of design, cost, and administration. A drug benefit could add between 7 and 13 percent per year to Medicare costs over the next decade. If such a benefit were added to Medicare, policymakers would have to decide who should bear these costs and whether subsidies should be provided to help lower income beneficiaries pay the portion of the costs borne by participants.

Why it matters

OpenAlex reports 19 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Even though almost two-thirds of Medicare beneficiaries have some coverage for outpatient prescription drugs, pharmaceuticals are a major part of their out-of-pocket expenses and threaten the financial security of growing numbers of beneficiaries. Because pharmaceuticals are an integral part of modern health care, some have proposed adding a drug benefit to Medicare. Such proposals pose difficult questions of design, cost, and administration. A drug benefit could add between 7 and 13 percent per year to Medicare costs over the next decade. If such a benefit were added to Medicare, policymakers would have to decide who should bear these costs and whether subsidies should be provided to help lower income beneficiaries pay the portion of the costs borne by participants.

Key concepts: Prescription drug, Medicare Part D, Subsidy, Medical prescription, Drug, Business, Actuarial science, Prescription costs

Related papers

Back to paper searchBrowse research topicsOriginal source
A Medicare prescription drug benefit. — Research Paper | ScholarLens